QUALIblood: Our new partner in advancing the diagnosis of thrombosis risk
On 14 February 2025, QUALIblood and Diagnostica Stago formalised a strategic alliance focused on the development and future launch of a new reagent kit, nAPCsr – a thrombin generation test designed to assess thrombosis risk in women considering or currently using oestrogen-based hormonal treatments, particularly oral contraceptives.
Read more
A new look for Stago's scientific posters
Sharing and deepening knowledge is essential if we are to become a benchmark in the field of blood diagnostics. With this in mind, six scientific posters have been updated and redesigned to offer more up-to-date and accurate content.
Read more
Stago's 2024 CSR report is online
The Stago Group is strengthening its commitment to Corporate Social Responsibility (CSR) and publishing its first 2024 report.
Read more
How to maximize lab productivity? This was the question asked by Stago to our experts during ISTH.
This Presentation Theater was hosted by François Depasse, Director Clinical Development at Stago.
During this session, our experts explained how Stago solutions can support the laboratories to face their challenges, such as staff shortages and cost pressures while reaching the highest reliability of diagnostics.
The new version of the Quick Guide to Hemostasis is available!
The complete guide to hemostasis is back, in a completely updated and redesigned version. Alongside 11 in-depth chapters, it includes diagrams and tables to enhance understanding of hemostasis mechanisms.
Read more